DNA Analysis of Gestational Trophoblastic Disease
Repiská V.1, Vojtaššák J.1, Korbeľ M.2, Danihel Ľ.3, Šufl iarsky J.4, Nižňanská Z.2, Redecha M.2, Ilavská I.4
1Ústav lekárskej biológie a genetiky LF UK v Bratislave, prednosta doc. RNDr. J. Vojtaššák, CSc. 21. gynekologicko-pôrodnícka klinika LF UK a FN v Bratislave, prednosta prof. MUDr. M. Borovský, CSc. 3Ústav patologickej anatómie LF UK a FN v Bratislave, prednosta prof. MUDr. Ľ. Danihel, CSc. 4Národný onkologický ústav v Bratislave, riaditeľ prof. MUDr. I. Koza, DrSc. 1,2,3,4Centrum pre trofoblastovú chorobu SR, vedúci doc. MUDr. M. Korbeľ, CSc. |
|
Summary:
Objective: DNA analysis of different forms of gestational trophoblastic disease.
Design: Retrospective clinical study.
Setting: Slovak Center of Trophoblastic Disease, Bratislava, Slovak Republic.
Methods: In the period of September 1993 to April 2003, eighty-nine cases of gestational trophoblastic
disease were analysed. There were 22 cases of partial hydatidiform moles, 58 cases of complete
hydatidiform mole, 5 cases of invasive mole and 4 cases of gestational choriocarcinomas.
Southern hybridization and polymerase chain reaction were used for DNA analysis.
Results: From 22 analyzed cases of partial hydatidiform moles 19 (86.4%) were triploid and 3
(13.6%) diploid ones. There were 58 cases of complete hydatidiform mole and out of them 29 (50%) were homozygous, 28 (48.3%) heterozygous, and in one case (1.7%) both paternal and maternal
genome was detected. In 8 cases of heterozygous and in one case of homozygous complete hydatidiform
mole occurred a malignant transformation to gestational choriocarcinoma.
Conclusions: Molecular analysis can determine the nuclear DNA origin of complete hydatidiform
mole and allow us to defi ne the patients with higher risk of malignant transformation usually to
gestational choriocarcinoma.
Key words:
DNA analysis, gestational trophoblastic disease, hydatidiform mole, choriocarcinoma
|